Stem cells in chronic myeloid leukaemia.
作者信息
Pellicano Francesca, Holyoake Tessa L
机构信息
Section of Experimental Haematology, Division of Cancer Sciences & Molecular Pathology, University of Glasgow, UK.
出版信息
Cancer Biomark. 2007;3(4-5):183-91. doi: 10.3233/cbm-2007-34-503.
PMID:17917148
Abstract
摘要
相似文献
1
Stem cells in chronic myeloid leukaemia.
Cancer Biomark. 2007;3(4-5):183-91. doi: 10.3233/cbm-2007-34-503.
2
Haemangioblast origin of chronic myeloid leukaemia?
Lancet. 2000 May 13;355(9216):1659-60. doi: 10.1016/s0140-6736(00)02232-7.
3
Chronic myeloid leukemia stem cells: now on the run.
J Clin Oncol. 2009 Jan 10;27(2):313-4. doi: 10.1200/JCO.2008.19.2260. Epub 2008 Dec 8.
4
Getting to the root of the stem cell in mutated chronic myeloid leukemia.
Leuk Lymphoma. 2010 Dec;51(12):2147-8. doi: 10.3109/10428194.2010.531802.
5
SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 1997; 11: 1762-1768.
Leukemia. 1998 Jul;12(7):1168-70. doi: 10.1038/sj.leu.2401063.
6
Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia.
Leuk Lymphoma. 2008 Apr;49(4):604-9. doi: 10.1080/10428190801923212.
7
Chronic myeloid leukemia: reaching for the cure.
Curr Cancer Drug Targets. 2013 Sep;13(7):709-10. doi: 10.2174/15680096113139990091.
8
Molecular biology of chronic myeloid leukemia.
Int J Hematol. 2001 Apr;73(3):308-22. doi: 10.1007/BF02981955.
9
The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia.
Br J Haematol. 2018 Apr;181(1):137-139. doi: 10.1111/bjh.14508. Epub 2017 Feb 21.
10
A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.
Hematol Oncol. 2001 Sep;19(3):89-106. doi: 10.1002/hon.667.
引用本文的文献
1
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.
PLoS One. 2011 Apr 26;6(4):e19164. doi: 10.1371/journal.pone.0019164.
2
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy.
Int J Hematol. 2008 Dec;88(5):471-475. doi: 10.1007/s12185-008-0221-1. Epub 2008 Nov 29.
Zotero 插件